Rxo, INC
Market Movers (8-K)
NYSE
RXO
Rxo, INCRXO announced its first-quarter financial results, highlighting sequential improvements in full truckload volume and brokerage gross profit per load, while providing a second-quarter outlook anticipating significant profit improvement.
NYSE
RXO
Rxo, INCRXO, Inc. announced a private offering of $400 million in senior unsecured notes due 2031 to fund the conditional redemption of its outstanding 7.500% Notes due 2027.
Capital raise
NYSE
RXO
Rxo, INCRXO reported a wider net loss in the fourth quarter of 2025 as revenue declined and brokerage gross margins were squeezed by a tightening freight market.
Capital raise
Worse than expected
NYSE
RXO
Rxo, INCRXO, Inc. announced the appointment of Daniel Morris as its new Chief Accounting Officer, succeeding retiring Jason Kerr, effective May 15, 2026.
NYSE
RXO
Rxo, INCRXO announced its third-quarter 2025 financial results, reporting increased revenue but lower profitability metrics year-over-year, as a tightening full-truckload market and weakening demand impacted performance.
Worse than expected
NYSE
RXO
Rxo, INCRXO, Inc. reported strong second-quarter 2025 results, outperforming the soft freight market with significant revenue growth and improved adjusted profitability, driven by the Coyote Logistics acquisition and robust Last Mile performance.
Better than expected
Quarterly Earnings (10-Q)
NYSE
RXO
Rxo, INCRXO, Inc. reported a slight revenue decrease for the first quarter of 2026, with net loss widening due to increased costs and debt extinguishment charges, despite a rise in truck brokerage revenue.
Worse than expected
NYSE
RXO
Rxo, INCRXO, Inc. announced a significant increase in revenue and a substantial reduction in net loss for the third quarter and first nine months of 2025, largely driven by the Coyote acquisition.
Better than expected
NYSE
RXO
Rxo, INCRXO, Inc. reported a significant revenue increase in Q2 2025, primarily driven by the Coyote acquisition, despite an expanded net loss.
Worse than expected
NYSE
RXO
Rxo, INCRXO Inc.'s Q1 2025 results reflect increased revenue due to the Coyote acquisition, but also show a net loss and increased costs.
Worse than expected
NYSE
RXO
Rxo, INC10-Q: RXO Inc. Reports Third Quarter 2024 Results, Impacted by Coyote Acquisition and Market Conditions
RXO Inc.'s third quarter results for 2024 were significantly influenced by the acquisition of Coyote, alongside a decrease in legacy truck brokerage revenue due to lower load volumes and rates.
Worse than expected
Capital raise
NYSE
RXO
Rxo, INCRXO's second quarter results show a revenue decrease, offset by cost-cutting measures, while the company prepares for a significant acquisition.
Worse than expected
Annual Reports (10-K)
NYSE
RXO
Rxo, INCRXO, Inc. announced a 26.2% revenue increase to $5.742 billion in 2025, driven by the Coyote acquisition and last mile volume, despite reporting a net loss of $(100) million.
Worse than expected
NYSE
RXO
Rxo, INCRXO, Inc.'s 2024 10-K filing reveals a year of strategic acquisition and financial adjustments, including the integration of Coyote Logistics and a net loss driven by a one-time charge.
Worse than expected
Capital raise
NYSE
RXO
Rxo, INCRXO Inc.'s 2023 annual report reveals a decrease in revenue due to market rate pressures, while the company emphasizes its technology-driven strategy and cost management.
Worse than expected
Insider Trading (Form 4)
NYSE
RXO
Rxo, INCRXO, Inc. executive Daniel S. Morris received a grant of 13,377 Restricted Stock Units (RSUs) on May 15, 2026, vesting over three years.
NYSE
RXO
Rxo, INCRXO, Inc. CEO Andrew Wilkerson reported transactions involving restricted stock units and common stock, including shares withheld for tax liabilities.
NYSE
RXO
Rxo, INCRXO, Inc. CEO Andrew M. Wilkerson reported the vesting of 52,768 Restricted Stock Units, with 22,923 shares withheld for tax obligations.
NYSE
RXO
Rxo, INCRXO's Chief Accounting Officer, Jason S. Kerr, reported the vesting of restricted stock units and subsequent tax-related share withholding.
NYSE
RXO
Rxo, INCRXO's Chief Financial Officer, James E. Harris, reported the vesting of 12,989 Restricted Stock Units and the withholding of 5,643 shares for tax obligations.
NYSE
RXO
Rxo, INCRXO's Chief Legal Officer, Jeffrey D. Firestone, reported the vesting of 11,771 Restricted Stock Units and the withholding of 5,114 shares for tax obligations.
Proxy Statements (Def-14A)
NYSE
RXO
Rxo, INCRXO schedules a virtual May 12, 2026 annual meeting to elect directors, ratify Deloitte, expand its 2022 equity plan by 7 million shares, and hold an advisory say‑on‑pay vote.
NYSE
RXO
Rxo, INCRXO, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission pertaining to Section 14(a) of the Securities Exchange Act of 1934.
NYSE
RXO
Rxo, INCRXO, Inc. has set the date for its 2025 Annual Meeting of Stockholders and announced that Brad Jacobs will not seek reelection, with Drew Wilkerson slated to become the new Chairman.
Worse than expected
NYSE
RXO
Rxo, INCDEF 14A: RXO Inc. Seeks Stockholder Approval for Warrant Issuance to Fund Coyote Logistics Acquisition
RXO Inc. is holding a special meeting on December 5, 2024, to seek stockholder approval for the issuance of common stock upon the exercise of warrants, which were part of a private placement used to partially fund the acquisition of Coyote Logistics.
Capital raise
NYSE
RXO
Rxo, INCRXO, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to its upcoming shareholder meeting.
NYSE
RXO
Rxo, INCDEF 14A: RXO, Inc. Announces Details for 2024 Annual Stockholders Meeting and Executive Compensation
RXO, Inc. has released its proxy statement detailing the agenda for its 2024 Annual Meeting of Stockholders, including the election of directors, ratification of the independent auditor, and an advisory vote on executive compensation.
Worse than expected
Schedule 13G - Passive Investments
NYSE
RXO
Rxo, INCOrbis Investment Management Limited, Allan Gray Australia Pty Ltd, and Orbis Investment Management (U.S.), L.P. have collectively reported beneficial ownership of 22.1% of RXO, Inc.'s common stock as of March 31, 2026.
NYSE
RXO
Rxo, INCVanguard Capital Management has reported beneficial ownership of 8,570,903 shares, representing 5.21% of RXO Inc.'s common stock as of March 31, 2026.
NYSE
RXO
Rxo, INCVanguard Portfolio Management has reported beneficial ownership of 5.54% of RXO Inc.'s common stock as of March 31, 2026.
NYSE
RXO
Rxo, INCThe Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership of RXO Inc. common stock due to an internal corporate realignment.
NYSE
RXO
Rxo, INCSCHEDULE: Orbis Group Boosts RXO Stake to 21.1%
Orbis Investment Management Limited, Allan Gray Australia Pty Ltd, and Orbis Investment Management (U.S.), L.P. collectively reported beneficial ownership of 21.1% of RXO, Inc.'s common stock.
NYSE
RXO
Rxo, INCFinepoint Capital LP and Herbert Wagner have reported a 5.7% beneficial ownership stake in RXO, Inc., totaling 9,388,789 shares.